Beijing Luzhu Biotechnology Co., Ltd. (Luzhu Biotech) announced that the Hong Kong Stock Exchange has confirmed Mr. Liu Siyu’s compliance with Listing Rules 3.28 and 8.17, formally qualifying him to act as the company secretary without the need for further waivers.

Ms. Lai Ho Yan, previously serving as joint company secretary and authorised representative, resigned from both positions effective 12 June 2026. She will remain the company’s process agent in Hong Kong.

Following Ms. Lai’s departure, Mr. Liu will continue as the sole company secretary and has been appointed as the new authorised representative, also effective 12 June 2026.

The board expressed appreciation for Ms. Lai’s service and welcomed Mr. Liu’s expanded responsibilities. As of the announcement date, the board comprises three executive directors, two non-executive directors and three independent non-executive directors.